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case report
Transient neonatal hypothyroidism 
in a boy with unbalanced 
translocation t(8;16)
Hipotireoidismo neonatal transitório em um menino 
com translocação não balanceada t(8;16)
Luciana A. de A. Secchi1, Juliana F. Mazzeu2, Mara Santos Córdoba3, 
Íris Ferrari2, Helton Estrela Ramos4, Francisco de Assis Rocha Neves1
SUMMARY
Genetic defects resulting in deficiency of thyroid hormone synthesis can be found in about 
10% of the patients with permanent congenital hypothyroidism, but the identification of ge-
netic abnormalities in association with the transient form of the disease is extremely rare. We 
report the case of a boy with transient neonatal hypothyroidism that was undiagnosed in the 
neonatal screening, associated with extrathyroid malformations and mental retardation. The 
boy carries an unbalanced translocation t(8;16), and his maternal uncle had a similar pheno-
type. Chromosomal analysis defined the patient’s karyotype as 46,XY,der(8)t(8;16)(q24.3;q22)
mat,16qh+. Array-CGH with patient’s DNA revealed a ~80 kb terminal deletion on chromosome 
8q24.3qter, and a ~21 Mb duplication on chromosome 16q22qter. ZNF252 gene, mapped to 
the deleted region on patient’s chromosome 8, is highly expressed in the thyroid, and may 
be a candidate gene for our patient’s transient neonatal thyroid dysfunction. This is the first 
report on the association of a chromosomal translocation with the transient form of congenital 
hypothyroidism. This description creates new hypothesis for the physiopathology of transient 
congenital hypothyroidism, and may also contribute to the definition of the unbalanced trans-
location t(8;16)(q24.3;q22) phenotype, which has never been described before. Arq Bras Endocrinol 
Metab. 2012;56(8):564-9 
SUMÁRIO
Defeitos genéticos resultando em deficiência hormonal tireoidiana podem ser encontrados em 
cerca de 10% dos pacientes com hipotireoidismo congênito permanente, porém a identificação 
de anormalidades genéticas associadas à forma transitória da doença é extremamente rara. Re-
latamos o caso de um menino com hipotireoidismo neonatal transitório não diagnosticado no 
teste de triagem neonatal, associado a malformações extratireoidianas e retardo mental. O pa-
ciente é portador de translocação não balanceada t(8;16), e seu tio materno tinha fenótipo simi-
lar. A análise cromossômica definiu o cariótipo do paciente como 46,XY,der(8)t(8;16)(q24.3;q22)
mat,16qh+. A análise cromossômica array-CGH com o DNA do paciente revelou deleção termi-
nal de ~80 kb no cromossomo 8q24.3qter, e duplicação de ~21 Mb no cromossomo 16q22qter. 
O gene ZNF252, mapeado na região da deleção no cromossomo 8 do paciente, é altamente 
expresso na tireoide e pode ser um gene candidato no hipotireoidismo neonatal transitório 
do paciente. Esse é o primeiro relato de associação de uma translocação cromossômica com 
a forma transitória do hipotireoidismo congênito. Essa descrição descortina novas hipóteses 
para a fisiopatologia do hipotireoidismo congênito transitório e também pode contribuir para 
a definição do fenótipo da translocação não balanceada t(8;16)(q24.3;q22), nunca descrito 
anterior mente. Arq Bras Endocrinol Metab. 2012;56(8):564-9 
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INTRODUCTION
Congenital hypothyroidism (CH), a deficiency of thyroid hormone at birth (1), is the most com­
mon congenital endocrine abnormality (2). In gene­
ral, the condition is permanent; however, some cases 
are transient – showing a temporary hormonal deficit 
– and patients do not need lifelong levothyroxine re­
placement, since recovery of euthyroidism occurs in the 
first few months or years of life (1,3­5). Since normal 
thyroid function is essential for development, growth 
and metabolic homeostasis, transient congenital hypo­
thyroidism (TCH), if not diagnosed or not correctly 
treated, may cause a deficit in intelligence (6). 
TCH can be caused by genetic or non­genetic fac­
tors, such as immunologic, environmental or iatro­
genic, maternal, or neonatal factors (1,7,8). In the last 
decade, genetic abnormalities have been identified in 
some patients, most of them in genes encoding proteins 
involved in thyroid generation of hydrogen peroxide 
(H2O2) – thyroid­oxidase or dual­oxidase 2 (DUOX2), 
and dual­oxidase maturation factors (DUOXA1 and 
DUOXA2) (9­13).
Description and genetic analysis of patients with CH 
may provide important information about the etiology 
and physiopathology of thyroid diseases, especially in 
those with syndromic and familial forms of the disor­
der. We report the case of a boy with TCH associated 
with extra­thyroid malformations and mental retarda­
tion who carries an unbalanced translocation t(8;16), 
and whose maternal uncle had a similar phenotype.
CASE REPORT
A boy born from non­consanguineous parents after an 
uneventful full­term pregnancy, weighting 2,250 g (< 
3rd percentile), presented ocular hypertelorism, deviat­
ed nasal septum, choanal atresia, umbilical hernia, hy­
pospadia, imperforate anus and bradycardia. In the first 
day of life, he was submitted to surgical treatment for 
choanal and anal abnormalities. On 7th day of life, neo­
natal screening for CH was negative, with TSH 7.09 
mU/mL (cutoff level of TSH used in the screening test 
was 20 mU/mL), and total T4 16.4 g/dL (reference 
range 4.5­22.20 mg/dL). The presence of dry skin, 
umbilical hernia, and developmental delay led to clini­
cal suspicion of CH, and when the boy was 3 months 
old, new thyroid function tests were performed and 
showed severe thyroid hormone deficiency (undetect­
able serum free T4) associated with serum TSH of 4.97 
mU/mL (reference range 0.49­4.67 mU/mL). Levo­
thyroxine replacement therapy was started (10.1 mg/kg 
daily) and, six weeks later, thyroid function parameters 
were normal (serum TSH 0.79 mU/mL; serum free T4 
1.18 g/dL, reference range 0.7­1.9). 
When the patient was seven months old, his bone 
age was compatible with that of a one­month­old baby. 
Two months later, he was referred to an endocrinolo­
gist for further investigation. Karyotype was performed 
and disclosed a chromosome unbalanced translocation 
(see below). Computed tomography of the central ner­
vous system showed no anatomic abnormalities. Ab­
dominal and pelvic ultrasound and echocardiography 
were normal.
Levothyroxine doses were progressively reduced 
from 10.1 to 4.9 mg/kg/day at eleven months of age. 
The patient had irregular follow­up from 1 to 4 years 
old. Nevertheless, all thyroid function tests performed 
during that period were normal. When the boy reached 
the age of 3 years and 10 months, levothyroxine dose 
was 2.5 μg/kg/day. Thyroid hormone replacement 
therapy was then discontinued. Thyroid ultrasound was 
performed one month later and showed a small­sized 
gland (0.75 cm3) with normal morphology located in 
the anterior face of the neck. Thyroid scintigraphy con­
firmed an orthotopic hypoplastic gland. Thyroglobu­
lin serum concentration was normal (17.4 ng/mL, 
reference range 2.0­60.0 ng/mL), and thyroid auto­
antibodies were not detected. Since then, the patient 
remains euthyroid. He had moderate deficit of motor 
coordination associated with impaired walking due to 
muscle hypertonia, and delayed speech, but intensive 
physical and speech therapy since his first years of life 
have improved his condition significantly. He is able to 
write his name and read simple words, and has achieved 
functional independence in self­care. He underwent 
surgery for hypospadia and deviated nasal septum. In 
all patient’s visits, growth rate was found to be normal, 
ruling out growth hormone deficiency. The boy, now 
aged 12, shows the first signs of puberty.
Genetic analysis
Chromosomal analysis after G-banding (550 band 
resolution) of peripheral blood lymphocytes 
The proband’s karyotype showed a derivative chro­
mosome 8 der(8) resulting from a translocation t(8;16) 
with breakpoints in 8q24.3 and 16q22 inherited from 
his mother, who carries a balanced reciprocal translo­
cation (Figures 1 and 2). One chromosome 16 pre­
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sents large heterochromatin, which represents a poly­
morphism without clinical significance (16qh+). The 
proband’s karyotype (ISCN 2009) was then defined as 
46,XY,der(8)t(8;16)(q24.3;q22)mat,16qh+. 
Array-CGH
For further mapping of the rearrangement, copy num­
ber variations of DNA segments (CNV) were investi­
gated in the patient using the Human Genome Com­
parative Genomic Hybridization (CGH) microarray 
60K (Agilent Technologies, Santa Clara, CA). The 
statistical algorithm ADM­2 was used with a 6.7 sensi­
tivity threshold, and the minimum number of consecu­
tive aberrant probes was set at three to determine an 
abnormality. The average size for CNV detection was 
300 Kb. 
Array­CGH with proband’s DNA revealed a ~80 kb 
terminal deletion on chromosome 8q24.3qter (chr8: 
146164694­146245835 Build 36/Hg18) and a ~21 
Mb duplication on chromosome 16q22qter (chr16: 
67957802­88893296 Build 36/Hg18). The genome 
browsers UCSC (http://genome.ucsc.edu) and En­
sembl (http://www.ensembl.org) were used to assess 
the known genes mapped to the involved segments. The 
deletion on chromosome 8 includes only two known 
genes, ZNF252 and C8ORF77, and a putative pseudo­
gene, all with unknown function. The duplication on 
chromosome 16 extend from band q22.1qter and in­
cludes approximately 283 genes (NCBI build 36.3 Sep­
tember 15th 2011). No genes mapped to this segment 
have been previously related to hypothyroidism. 
Patient’s maternal uncle
We accessed the medical records of the patient’s ma­
ternal uncle, a boy born at full­term in pelvipodalic 
presentation, small for gestational age (1,900 g; < 3rd 
Figure 1. Translocated chromosomes 8 and 16 from the patient’s 
karyotype.
Figure 2. Schematic representation of patient’s mother’s (balanced) and 
patient’s (unbalanced) translocation t(8;16). Balanced translocation: 
genetic material was transferred from chromosome 8 long arm 
(8q24.3qter) to chromosome 16 long arm (16q), and from 16q (16q22qter) 
to 8q. Unbalanced translocation: the patient inherited normal chromosomes 
from his father, an abnormal chromosome 8  from the mother, and one 
normal chromosome 16 from the mother, resulting in terminal deletion in 
one chromosome 8, and partial trisomy of chromosome 16.
Mother’s
Chromosomes 8 and 16
Patient’s









We also analyzed the chromosomes of other 21 out 
of 37 family members spanning four generations, and 
a balanced translocation t(8;16) was found in other 
three phenotypically normal family members (the pa­
tient’s mother, one maternal uncle, and the mater­
nal grandfather) (Figure 3). All of them are asymp­
tomatic, and no thyroid dysfunction or autoimmune 
thyroid diseases were detected. The patient’s mother 
and her brother inherited the balanced translocation 
from their father, whose parents are still alive and have 
normal karyotypes. Mental retardation is present in 
six other family members who do not have any chro­
mosome abnormalities and reported other causes for 
their deficits. 
Figure 3. Family pedigree. Black and white individuals (II1, III5 and III6) 
have a balanced translocation t(8;16). Individuals in black have an 
abnormal phenotype, including hypothyroidism. Chromosomal analysis 
was performed on individuals I1, I2, II1, II2, III3, III4, III5, III6, IV2, and IV3, 
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percentile), with persistent neonatal jaundice. At the 
time when he was born (22 years ago) screening test 
for CH was not yet being performed routinely in his 
area. At the age of four months, he was diagnosed with 
severe hypothyroidism, and was promptly treated. At 
eight months of age he was admitted to the hospital 
because of tracheobronchitis. His weight was 4,780 g 
(3 kg below ­2 SD), and height was 64 cm (­2 SD). He 
presented syndromic features – a wide anterior fontanel, 
oblique palpebral fissures, ocular hypertelorism, ogival 
palate, micrognathia, microstomia, and retractile tes­
tes. He also was hypoactive and presented psychomo­
tor delay, not being able to sit or hold objects. Despite 
receiving levothyroxine therapy (9.15 mcg/kg daily), 
the patient was still hypothyroid (TSH 12.97 mU/mL 
– normal range for the method was < 7.0 mU/mL; T4 
5.3 mg/dL – reference range 6­16.5 mg/dL). Thyroid 
hormone replacement dose was adjusted, tracheobron­
chitis was treated, and the patient was discharged from 
the hospital. He died two months later (at the age of 
ten months). No further information was found, and 
the patient’s karyotype was not studied.
DISCUSSION
One of the remaining challenges in thyroid disease 
physiopathology is the etiologic diagnosis of CH. Ge­
netic causes are rarely identified (2). 
 Our patient had a syndromic form of transient hy­
pothyroidism associated with mental retardation and 
an unbalanced translocation inherited from his mother. 
His maternal uncle presented common phenotypic fea­
tures, suggesting a similar chromosome abnormality 
inherited from his father. From all the 23 family mem­
bers who were studied, the proband and his deceased 
maternal uncle were the only ones who had confirmed 
hypothyroidism. All the family members with balanced 
translocation t(8;16) are asymptomatic and euthyroid. 
Oakley and cols. documented much higher preva­
lence of extrathyroid malformations in patients with 
transient (14.8%) than in those with permanent CH 
(5.4%). Nevertheless, of their 344 patients, a chromo­
somal imbalance – t(14;15) – was diagnosed in only 
one patient with permanent CH, even though it was 
not clear how many patients underwent chromosomal 
analysis (14).
Interestingly, some of the extrathyroid malforma­
tions found in our patient, such as hypospadia (15,16), 
choanal atresia, and anal stenosis (17) have already 
been described in association with terminal duplica­
tions of chromosome 16 overlapping with the region 
duplicated in the proband. However, none of these pa­
tients presented hypothyroidism. 
A complex clinical syndrome involving permanent 
hypothyroidism, tuberous sclerosis, sclerosis complex, 
adult polycystic kidney disease, and hypomelanosis of 
Ito has been associated to an unbalanced translocation 
t(8;16)(q24.3;p13.3)pat. Nevertheless, different from 
our case, the patient’s family members had already been 
diagnosed with thyroid diseases (18). Our case report 
is, to the best of our knowledge, the first to describe a 
patient with TCH and t(8;16). 
Genetic mutations or partial deletion in patients 
with TCH were described in genes encoding DUOX2, 
and/or DUOXA1 and DUOXA2 (9­13). In spite of 
this, none of the known candidate genes involved in 
the thyroid hormone synthesis have been mapped to 
the deleted segment on our patient’s chromosome 8, 
or to the duplicated segment on chromosome 16. Even 
the thyroglobulin gene (TG), mapped to the long arm 
of chromosome 8, is out of the deleted region (~12 Mb 
from breakpoint). 
The patient’s thyroid phenotype seems to be related 
to his unbalanced translocation t(8;16), since the ba­
lanced translocation observed in his relatives is not as­
sociated with any dysfunction. Considering the size of 
the chromosome 16 duplicated segment, it is possible 
that the partial trisomy 16q is involved with the pa­
tient’s syndromic phenotype.
Notwithstanding, we cannot exclude the fact that 
the partial deletion of the chromosome 8 can partici­
pate on the physiopathology of the transient hypothy­
roidism observed in our patient, mainly because of the 
ZNF252 gene, which belongs to the zinc finger genes, 
one of the largest transcriptional gene regulation family. 
Although its function is still unknown, ZNF252 is high­
ly expressed in the thyroid, suggesting a prominent role 
of the gene in that tissue (19). Consequently, haploin­
sufficiency of ZNF252 may be involved in our patient’s 
TCH. Nonetheless, new studies reporting the associa­
tion of mutations in this gene with CH patients and 
knockout animals should address the role of ZNF252 
in thyroid function. A case report recently published 
described ZNF764 (mapped to chromosome 16q) hap­
loinsufficiency in a patient with mental retardation, hy­
pospadia, and thyroid hormone resistance (20).
Our patient had transient severe hypothyroidism with 
undetectable serum T4 in his third month of life, but 
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with inappropriately normal serum TSH for the severity 
of thyroid hormone deprivation, suggesting central ner­
vous system involvement. At the time of diagnosis, the 
patient was not assisted by endocrinologists and a dose­
response curve with TRH stimulus had not been per­
formed. In the beginning of our study, the patient was 
euthyroid and on thyroid hormone reposition; therefore, 
TRH testing was not considered at that time. After levo­
thyroxine discontinuation, we decided not to carry out 
the TRH test because the probability of a positive test 
was extremely remote and there were ethical concerns. 
Indeed, the patient presented normal growth, nor­
mal puberty, and no signs of combined pituitary defi­
ciency. None of the known genes related to develop­
ment of the thyroid regulatory system or TSH synthesis, 
including TRH, TSHb, and TRH-R, are mapped to chro­
mosomal regions affected in our patient’s unbalanced 
translocation. 
Regardless of the possible misdiagnosis of CH in 
the patient’s first week of life, it is difficult to explain 
why he had TSH levels over 7 mU/mL on the 7th day 
and not later, when T4 levels were undetectable, but 
serum TSH concentration remained under 5 mU/mL. 
It is also possible that initial thyroid hormone levels 
would have reflected an euthyroid state that dramati­
cally changed later on, as he presented hypothyroidism 
with features of central involvement. 
We believe that this description creates new hypo­
thesis for the physiopathology of transient congenital 
hypothyroidism. Moreover, our case report may also 
contribute to genetic counseling, and to the definition 
of the phenotype of the unbalanced translocation t(8;16)
(q24.3;q22), which has never been described before. 
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